Your browser doesn't support javascript.
loading
Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.
Hilmi, Marc; Bally, Cécile; Burns, Robert; Lorillon, Gwenael; Bergeron, Anne; Fenaux, Pierre; Ades, Lionel.
Afiliação
  • Hilmi M; Hopital Saint Louis and Paris 7 university, 1 avenue Claude Vellefaux, 75010, Paris, France.
  • Bally C; Hopital Saint Louis and Paris 7 university, 1 avenue Claude Vellefaux, 75010, Paris, France.
  • Burns R; Department of Radiology, Groupe Hospitalier Cochin-Hotel Dieu APHP, University Paris 5, Paris, France.
  • Lorillon G; Medical Pneumology Department, Hôpital Saint Louis APHP, University Paris 7, Paris, France.
  • Bergeron A; Medical Pneumology Department, Hôpital Saint Louis APHP, University Paris 7, Paris, France.
  • Fenaux P; Hopital Saint Louis and Paris 7 university, 1 avenue Claude Vellefaux, 75010, Paris, France.
  • Ades L; Hopital Saint Louis and Paris 7 university, 1 avenue Claude Vellefaux, 75010, Paris, France. Lionel.ades@aphp.fr.
Ann Hematol ; 97(3): 541-542, 2018 Mar.
Article em En | MEDLINE | ID: mdl-29170809
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mielomonocítica Crônica / Doenças Pulmonares Intersticiais / Antimetabólitos Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mielomonocítica Crônica / Doenças Pulmonares Intersticiais / Antimetabólitos Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França